|
¡¡ |
Abstract |
|---|
|
Top |
|---|
The synthetic pathway by which 5
-androstane-3
,17ß-diol (5
-adiol) is formed in the testes of tammar wallaby pouch young was investigated by incubating testes from d 20¨C40 males with various radioactive precursors and analyzing the metabolites by thin-layer chromatography and HPLC. [3H]Progesterone was converted to 17-hydroxyprogesterone, which was converted to 5
-adiol by two pathways: One involves the formation of testosterone and dihydrotestosterone as intermediates, and the other involves formation of 5
-pregnane-3
,17
-diol-20-one (5
-pdiol) and androsterone as intermediates. Formation of 5
-adiol from both [3H]testosterone and [3H]progesterone was blocked by the 5
-reductase inhibitor 4MA. The addition of nonradioactive 5
-pdiol blocked the conversion of [3H]progesterone to 5
-adiol, and [3H]5
-pdiol was efficiently converted to androsterone and 5
-adiol. We conclude that expression of steroid 5
-reductase in the developing wallaby testes allows formation of 5
-reduced androgens by a pathway that does not involve testosterone as an intermediate.
| ¡¡ | Introduction |
|---|
| Top Abstract Introduction Materials and Methods Results Discussion References |
|---|
5
The pathway by which 5
-adiol is synthesized is not entirely clear. We showed that 5
-adiol can be formed from testosterone in tammar pouch young testes (1), but Eckstein et al. (12) reported that the predominant pathway of 5
-adiol synthesis in immature rat testes involves 17-hydroxyprogesterone (17-OHP) but not androstenedione as an intermediate. Presumably, 5
-adiol formation in the immature testes involves one or more 5
-reduced intermediates because the levels of isoenzymes 1 and 2 of steroid 5
-reductase are high in rat testes at d 30 and decline rapidly thereafter (13) and because both progesterone and 17-OHP are better substrates for 5
-reductase than testosterone itself (14). In keeping with this possibility, Tsujimura and Matsumoto identified a variety of 5
-reduced pregnanes and androgens in immature mouse testes (15). To define the pathway of 5
-adiol formation in tammar wallaby pouch young, we studied the metabolism of [3H]progestogens and [3H]testosterone in testes removed from pouch young during the period when the male urogenital sinus virilizes (d 20¨C45 postpartum).
| ¡¡ | Materials and Methods |
|---|
| Top Abstract Introduction Materials and Methods Results Discussion References |
|---|
Animals
Tammar wallabies (Macropus eugenii) that originated in Kangaroo Island, South Australia, were held in a breeding colony in open yards. Their diet was supplemented with lucerne hay, oats, and fresh vegetables. All experiments followed guidelines of the National Health and Medical Research Council of Australia (1977) and were approved by the Animal Experimentation Ethics Committee of the University of Melbourne. Females were checked regularly for the presence of pouch young, and pouch young ages were determined either from known birth dates or extrapolated from growth curves using head length measurements (16). The sex of each pouch young was identified by the presence of scrotal bulges (males) or pouch and mammary gland primorida (females) (17).
Methods
The pouch young were killed by decapitation (18), and the testes were removed, weighed, dissected free of adjacent structures under a dissecting microscope, and kept in ice-cold normal saline until used for incubations. For the in vitro incubation studies, gonads were blotted, weighed, and added to glass tubes containing radioactive steroids in 50 µl DMEM and some instances either 4 µl ethanol or nonradioactive steroids or 17ß-N,N-diethyl-carbamoyl-4-methyl-4-aza-5
-androstane-3-one (4MA) dissolved in 4 µl ethanol (19). The tubes were gassed for 30 sec with 95% oxygen-5% carbon dioxide, capped, and incubated with shaking at 37 C for varying periods of time. The reactions were stopped by the addition of 1 ml chloroform/methanol (2:1), and the samples were dried under air at room temperature. The residues were dissolved in 0.2 ml chloroform/methanol (2:1).
For thin-layer chromatography (TLC), 10-µl aliquots were spotted on 20 x 20-cm TLC plastic sheets coated with silica gel 60 (Merck, Darmstadt, Germany) together with 10 µg each of carrier steroids (progesterone, 17-OHP, 5-dihydroprogesterone, 5
-adiol, dihydrotestosterone, testosterone, androsterone, androstenedione, 5-androstanedione, and in some studies 5
-pregnane-3
,17
-diol-20-one (5-pdiol). The plates were developed in chloroform:toluene:acetone (50:80:20) for 45 min and air dried; steroids were visualized by spraying with 1% p-anisaldehyde in glacial acetic acid:sulfuric acid (100:2) and heating the plates in an oven at 100 C for 15 min. Each lane was then cut into 10 fractions corresponding to the visualized carrier steroids, and the entire lane was assayed for radioactivity in a liquid scintillation counter.
For separation by HPLC, the residues were dissolved in 100 µl methanol, and aliquots were injected into an 840 instrument (Waters, Woburn, MA) and separated on a 10-µm C18 Bondpak column (3.9 x 300 mm) using a gradient of 60¨C100% methanol and water. In the standard 45-min run, the initial 23 min was at 64% methanol followed by a 7-min gradient to 100% methanol followed by 15 min at 100% methanol. The column effluent was analyzed with a 757 absorbance detector (Spectraflow, Waters) set at 254 nm and a ß-RAM radioactive flow detector (INUS Systems, Inc., Tampa, FL). Under these conditions the elution times (in minutes) were as follows: androstenedione, 13.7; testosterone, 16.8; 17-OHP, 17.8; dihydrotestosterone, 26.0; progesterone 32.6; androsterone, 33.8; 5-adiol, 34.2; and 5
-pdiol, 35.4.
Materials
[1,2,6,7-3H]Progesterone [3.8 TBq/mmol] and [7-3H]pregnenolone (0.5 TBq/mmol) were from NEN Life Science Products, Boston MA; 17-hydroxy[1,2,6,7-3H]progesterone (2.40 TBq/mmol) and [1,2,6,7-3H]testosterone (3.70 TBq/mmol) were from Amersham Pharmacia. [1,2,6,7-3H]5
-pregnane-3
,17
-diol-20-one was prepared as described by hydroxylation of [1,2,6,7-3H]5
-pregnane-3
-ol-20-one (3.8 TBq/mmol) (NEN Life Science Products) with microsomes that express a mutant human 17-hydroxylase (CYP 17) that is selectively deficient in 17,20-lyase activity (19). [1,2-3H]5-dihydroprogesterone was prepared by enzymatic reduction of [1,2-3H]progesterone (1.8 TBq/mmol, NEN Life Science Products) using microsomes from yeast that express human steroid 5
-reductase 2 as described (19). The nonradioactive steroids were from Steraloids, Inc. (Newport, RI) or Sigma (St. Louis, MO). The 5
-reductase inhibitor 4MA was a gift of Merck (20).
| ¡¡ | Results |
|---|
| Top Abstract Introduction Materials and Methods Results iscussion References |
|---|
In preliminary experiments d 49 tammar pouch young testes were incubated with 5 µM [3H]pregnenolone for 2 h, and the incubation products were separated by TLC and assayed for radioactivity, and the majority of radioactivity was recovered in progesterone and 17-OHP (46 and 56 nmol/mg testis¡¤2 h, respectively), compared with 17-hydroxypregnenolone (6.4 nmol/mg testis¡¤2 h). We concluded that the predominant system for androgen synthesis in this species is via the
To investigate the concept that 5
-adiol could be synthesized by a pathway not involving androstenedione as a substrate, we considered the possibility that 5
-dihydroprogesterone might be an intermediate in the pathway because progesterone is a better substrate for steroid 5
-reductase than testosterone or androstenedione (14). However, [3H]progesterone did not appear to be converted in significant amounts to [3H]5
-dihydroprogesterone (results not shown), and when 5 µM [3H]progesterone and 5 µM [3H]5
-dihydroprogesterone were compared as substrates for 5
-adiol formation in pouch young testes in two experiments, the rate of formation from progesterone was almost twice that from dihydroprogesterone (average of 10.0 vs. 5.2 pmol/h per two testes). Thus, 5
-dihydroprogesterone is probably not a significant intermediate in the conversion of progesterone to 5
-adiol. However, as illustrated in Fig. 1 (and found consistently), pouch young testes converted [3H]progesterone to a variety of metabolites including 17-OHP, testosterone, 5
-adiol, androsterone/dihydrotestosterone (which did not separate in this system), and another metabolite that chromatographed in a region between 5
-adiol and the origin. In time sequence studies, the unknown metabolite was detectable after the appearance of 17-OHP, and its formation was blocked by the addition of the steroid 5
-reductase inhibitor 4MA (results not shown). We therefore deduced that the metabolite was probably a 5
-reduced derivative of 17-OHP, which is also an excellent substrate for steroid 5
-reductase (14).
|
On the basis of chromatography studies using five different solvent systems for TLC and three different programs for elution of HPLC with methanol and water, we tentatively identified the unknown metabolite not as the predicted metabolite 5-pregnane-17
When testes from d 35 pouch young were incubated with 5 µM [3H]progesterone, [3H]17-OHP, or [3H]5
-pdiol, 17-OHP was a better substrate than progesterone for the formation of testosterone and 5-adiol, whereas [3H]5-pdiol was converted to androsterone and 5-adiol but not to 4 metabolites (Table 1). The fact that [3H]5-pdiol was converted to androsterone and 5-adiol was in keeping with our interpretation that this compound is an intermediate in 5-adiol synthesis. Furthermore, in trapping experiments in which excess 17-OHP or 5-pdiol was added to incubations of pouch young testes with [3H]progesterone, 17-OHP inhibited the formation of testosterone and 5-adiol similarly, whereas 5-pdiol inhibited the formation of 5-adiol but had little effect on the formation of testosterone (Table 2). Inhibition of steroid 5-reductase with 5 µM 4MA blocks the conversion of [3H]progesterone to 5-adiol and 5-pdiol but does not impair the formation of 17-OHP or testosterone (Fig. 2).
|
|
|
These various experiments indicated that 17-OHP is metabolized by a 5-reduced pathway to 5-adiol and by a 4 pathway to testosterone, which we had previously shown can also be metabolized to 5-adiol (1). To provide insight into the relative importance of these two pathways of 5-adiol formation, 5 µM [3H]testosterone and 5 µM [3H]progesterone were compared as substrates for the formation of 5-adiol in d 34 pouch young testes (Fig. 3). After 2 h approximately twice as much 5-adiol was formed from progesterone as from testosterone (8.2 vs. 3.8 pmol/mg testis¡¤2 h), and the formation of 5-adiol from both substrates was inhibited by 4MA. These findings are in keeping with the interpretation of Eckstein et al. (12) that the predominant pathway of 5-adiol formation in the immature rat testis does not involve androstenedione as an intermediate.
|
In immature rat testes, the capacity to form 5-adiol declines (6) in parallel with the decrease in the activity of the steroid 5-reductase isoenzymes (13). In the oldest pouch young testes examined in the present study (d 54), the conversion of [3H]progesterone to 5-adiol and testosterone were similar (Fig. 4), implying that 5-reductase activity had not started to decline by this age.
|
| ¡¡ | Discussion |
|---|
| Top Abstract Introduction Materials and Methods Results Discussion References |
|---|
The present studies indicate that 5
|
In all mammals studied to date [with the exception of the Australian phalanger (Tricosurus vulpecula) in which large amounts of 5
Evidence of a variety of types suggests that 5-adiol virilizes tammar wallaby pouch young, at least in part, via oxidation of the 3
-hydroxyl to form dihydrotestosterone and dihydrotestosterone mediates the androgenic effect by binding to the androgen receptor (2, 3). Under most circumstances dihydrotestosterone is formed in extraglandular tissues by the 5
-reduction of testosterone, whereas in the tammar pouch young intracellular dihydrotestosterone appears to be formed by the oxidation of 5-adiol (1). It is not known whether circulating 5
-adiol also has actions in the tammar wallaby that are not mediated exclusively by the androgen receptor, e.g. via a cell surface receptor (27, 28) or by interacting with -aminobutyric acid receptors (29).
It is well established that active androgens can be synthesized by two general pathways, depending on the enzymatic composition of individual species. The 5 pathway involves pregnenolone 17-hydroxypregnenolone dehydroepiandrosterone androstenediol testosterone, and the 4 pathway involves pregnenolone progesterone 17-hydroxyprogesterone androstenedione testosterone. In both pathways the end product is testosterone, which can serve as a precursor for 5-reduced androgens in either the gonads or in extraglandular tissues. The fact that 5-adiol (and dihydrotestosterone) can be formed in the immature gonads of several species by another pathway, apparently determined by the expression of steroid 5-reductase, raises the possibility that 5
-adiol is in fact a primordial hormone of the testes. Why two different mechanisms evolved for the synthesis of dihydrotestosterone is unclear. We speculate that a high level of 5-reductase in the testes during the time of virilization of the male genitalia causes most 19-carbon steroids to be 5reduced and hence ready dihydrotestosterone precursors. The pathway of 5
-adiol formation via 5-pdiol circumvents two kinetic barriers to testosterone synthesis, namely 17-OHP is superior to testosterone as a substrate for 5-reductase (13) and 5
-pdiol appears to be the best substrate for the 17,20-lyase activity of CYP17 (19). The 5-pdiol pathway would thus assure efficient production of 19-carbon steroids even in species such as the human in which 17,20-lyase function of CYP17 is inefficient with 4 steroids (30). In summary, the formation of 5-adiol in fetal and neonatal testes of several species may be the most efficient route to dihydrotestosterone formation as a consequence of inherent properties of the synthetic enzymes.
¡¡
| ¡¡ | Acknowledgments |
|---|
Dr. Byron H. Arison (Merck Sharp & Dohm Research Laboratories, Rahway, NJ) generously performed nuclear magnetic resonance spectroscopy to confirm the assigned structure of 5
Received July 16, 2002.
Accepted for publication October 23, 2002.
| ¡¡ | References |
|---|
| Top Abstract Introduction Materials and Methods Results Discussion References |
|---|
- Shaw G, Renfree MB, Leihy MW, Shackleton CHL, Roitman E, Wilson JD 2000 Prostate formation in a marsupial is mediated by the testicular androgen 5-androstane-3
, 17ß-diol. Proc Natl Acad Sci USA 97:12256¨C12259
- Leihy MW, Shaw G, Wilson JD, Renfree MB 2001 Virilization of the urogenital sinus of the tammar wallaby is not unique to 5
-androstane-3
, 17ß-diol. Mol Cell Endocrinol 181:111¨C115
- Leihy MW, Shaw G, Renfree MB, Wilson JD 2002 Administration of 5
-androstane-3
, 17ß-diol to female tammar wallaby pouch young causes development of a mature prostate and male urethra. Endocrinology 143:2643¨C2651
- Chase DJ, Payne AH 1983 Changes in Leydig cell function during sexual maturation in the mouse. Biol Reprod 29:1194¨C1200
- Sheffield JW, O¡¯Shaughnessy PJ 1988 Testicular steroid metabolism during development in the normal and hypogonadal mouse. J Endocr 119:257¨C264
- Ge R-S, Hardy MP 1988 Variation in the end products of androgen biosynthesis and metabolism during postnatal differentiation of rat Leydig cells. Endocrinology 139:3787¨C3795
- Ge R-S, Hardy DO, Catterall JF, Hardy MP 1999 Opposing changes in 3
-hydroxysteroid dehydrogenase oxidative and reductive activities in rat Leydig cells during pubertal development. Biol Reprod 60:855¨C860
- Frungieri MB, Gonzalez-Calvar SI, Bartke A, Calandra RS 1999 Influence of age and photoperiod on steroidogenic function of the testis of the golden hamster. Int J Androl 22:243¨C252
- Risbridger GP, Davies A 1994 Isolation of rat Leydig cells and precursor forms after administration of ethane dimethane sulfonate. Am J Physiol 266:E975¨CE979
- Carmichael R, Belanger A, Cusan L, Seguin C, Caron S, Labrie F 1980 Increased testicular 5
-androstane-3
, 17ß-diol formation induced by treatment with [D-Ser (TBU)6, des-Gly-NH210]LHRH ethylamide in the rat. Steroids 36:383¨C391
- Moger WH 1977 Serum 5
-androstane-3
, 17ß-diol, androsterone, and testosterone concentrations in the male rat. Influence of age and gonadotropin stimulation. Endocrinology 100:1027¨C1032
- Eckstein B, Borut A, Cohen S 1987 Metabolic pathways for androstanediol formation in immature rat testis microsomes. Biochim Biophys Acta 924:1¨C6
- Pratis K, O¡¯Donnell L, Ooi GT, McLachlan RI, Robertson DM 2000 Enzyme assay for 5
-reductase type 2 activity in the presence of 5
-reductase 1 activity in rat testis. J. Steroid Biochem Mol Biol 75:75¨C82
- Frederiksen DW, Wilson JD 1971 Partial characterization of the nuclear reduced nicotinamide adenine dinucleotide phosphate:
4-3-keto-steroid 5
-oxidoreductase of rat prostate. J Biol Chem 246:2584¨C2593
- Tsujimura T, Matsumoto K 1974 Progesterone metabolism in vitro by mouse testes at different stages of development. Endocrinology 94:288¨C290
- Poole WE, Simms NG, Wood JT, Lubulwa M 1991 Tables for age determination of the Kangaroo island wallaby (Tammar), Macropus eugenii, from body measurements. In: Technical Memorandum No. 32. Canberra, Australia: Division of Wildlife and Ecology, Commonwealth Scientific and Industrial Research Organisation
- Wai-Sum O, Short RV, Renfree MB, Shaw G 1988 Primary genetic control of sexual differentiation in a mammal. Nature 331:716¨C717
- Wilson JD, George FW, Shaw G, Renfree MB 1999 Virilization of the male pouch young of the tammar wallaby does not appear to be mediated by plasma testosterone or dihydrotestosterone. Biol Reprod 61:471¨C475
- Gupta MK, Guryev OL, Auchus RJ, 5
-Reduced, C21 steroids are efficiently metabolized to dihydrotestosterone precursors by human CYP17. Program of the 84th Annual Meeting of The Endocrine Society, San Francisco, CA, 2002, p 276 (Abstract P1-527)
- Leshin M, Wilson JD 1982 Inhibition of steroid 5
-reductase from human skin fibroblasts by 17ß-N, N-diethylcarbamoyl-4-methyl-4-aza-5
-androstan-3-one. J Steroid Biochem 17:245¨C250
- Steckelbroeck S, Watzka M, Reichelt R, Hans VH, Stoffel-Wagner B, Heidrich DD, Schramm J, Bidlingmaier F, Klingmuller D 2001 Characterization of the 5-reductase-3
-hydroxysteroid complex in the human brain. J Clin Endocrinol Metab 86:1324¨C1331
- Matsumoto K, Yamada M, Tsujimura T 1976 Progesterone metabolism in vitro by rabbit testes at different stages of development. Endocrinology 99:1269¨C1272
- Chubb C, Ewing L, Irby D, Desjardins C 1978 Testicular in the rabbit: Secretion of testosterone, dihydrotestosterone, 5
-androstan-3
, 17ß-diol and 5
-androstan-3ß, 17ß-diol by perfused rabbit testes-epididymides and spermatogenesis. Biol Reprod 18:212¨C218
- Curlewis JD, Stone GM 1985 Peripheral androgen levels in the male brush-tail possum (Trichosurus vulpecula). J Endocr 105:63¨C70
- Curlewis JD, Stone GM 1985 Some effects of breeding season and castration on the prostate and epididymis of the brushtail possum, Tricosurus vulpecula. Aust J Biol Sci 38:3553¨C3559
- Viger RS, Robaire B 1995 Steady state steroid 5
-reductase messenger ribonucleic acid levels and immunocytochemical localization of the type I protein in the rat testis during postnatal development. Endocrinology 136:5409¨C5415
- Nakhla AM, Ding VD, Khan MS, Romas NA, Rhodes L, Smith RG, Rosner W 1995 5
-Androstan-3
, 17ß-diol is a hormone: stimulation of cAMP accumulation in human and dog prostate. J Clin Endocrinol Metab 80:2259¨C2262
- Ding VD, Moller DE, Feeney WP, Didolkar V, Nakhla AM, Rhodes L, Rosner W, Smith RG 1988 Sex-hormone binding globulin mediates androgen receptor action via a novel signaling pathway. Endocrinology 139:213¨C218
- Frye CA, van Keuren KR, Erskine MS 1996 Behavioral effects of 3
-androstanediol. I. Modulation of sexual receptivity and promotion of GABA-stimulated chloride flux. Behav Brain Res 79:109¨C118
- Auchus RJ, Lee TC, Miller WL 1998 Cytochrome b5 augments the 17, 20-lyase activity of human P450c17 without direct electron transfer. J Biol Chem 273:3158¨C3165
The Androgen Metabolite, 5-Androstane-3?, 17?-Diol, Is a Potent Modulator of Estrogen Receptor-?1-Mediated Gene Transcription in Neuronal Cells
12-Lipoxygenase Pathway Increases Aldosterone Production 3' 5'-Cyclic Adenosine Monophosphate Response Element-Binding Protein Phosphorylation and p38 Mitogen-Activated Protein Kinase Activation in H
A Transcriptionally Active Human Type II Gonadotropin-Releasing Hormone Receptor Gene Homolog Overlaps Two Genes in the Antisense Orientation on Chromosome 1q.12
Agouti-Related Peptide, Neuropeptide Y and Somatostatin-Producing Neurons Are Targets for Ghrelin Actions in the Rat Hypothalamus
Autosomal Dominant Growth Hormone Deficiency Disrupts Secretory Vesicles in Vitro and in Vivo in Transgenic Mice
Biological Activity of 17ß-Estradiol-3-Sulfate in Ovine Fetal Plasma and Uptake in Fetal Brain
Coexpression of Calcitonin Receptor-Like Receptor and Receptor Activity-Modifying Protein 2 or 3 Mediates the Antimigratory Effect of Adrenomedullin
Deletion of V335 from the L2 Domain of the Insulin Receptor Results in a Conformationally Abnormal Receptor That Is Unable to Bind Insulin and Causes Donohue s Syndrome in a Human Subject
Distribution of Vesicular Glutamate Transporter-2 Messenger Ribonucleic Acid and Protein in the Septum-Hypothalamus of the Rat
Dronerarone Acts as a Selective Inhibitor of 3,5,3'-Triiodothyronine Binding to Thyroid Hormone Receptor-1: In Vitro and in Vivo Evidence